D. Feller

D. Witiak, J. Hanson, H. A. Newman, 1989, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

In vivo and in vitro studies of the hepatotoxic effects of 4-chlorophenol in mice.

D. Feller, S. Phornchirasilp, J. Desouza, 1989, Biochemical pharmacology.

Inhibition of protein synthesis: a basis for tunicamycin-induced decrease in rat liver cytochrome P-450.

G. Krishna, D. Feller, V. Shirhatti, 1985, Life sciences.

Effects of synephrine and beta-phenethylamine on human alpha-adrenoceptor subtypes.

I. Khan, G. Ma, D. Feller, 2010, Planta medica.

Synthesis and human beta-adrenoceptor activity of 1-(3,5-diiodo-4- methoxybenzyl)-1,2,3,4-tetrahydroisoquinolin-6-ol derivatives in vitro.

Y. He, D. Miller, D. Feller, 2000, Journal of medicinal chemistry.

2-Amino-4-benzyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridines: novel selective beta3-adrenoceptor agonists.

D. Miller, D. Feller, S. Vansal, 1999, Journal of medicinal chemistry.

Serum lipoprotein and apoprotein concentrations in 4-(4-chlorophenyl)-2-hydroxytetronic acid and clofibrate-treated cholesterol and cholic acid-fed rats

D. Witiak, V. Kamanna, H. A. Newman, 2006, Lipids.

Synthesis and in vitro platelet aggregation and TP receptor binding studies on bicyclic 5,8-ethanooctahydroisoquinolines and 5,8-ethanotetrahydroisoquinolines.

V. Roche, K. Romstedt, D. Feller, 2002, Bioorganic & medicinal chemistry.

Accumulation of (-)-14C-ephedrine by the pigmented and the nonpigmented iris.

L. Malspeis, D. Feller, P. Patil, 1974, The Journal of pharmacology and experimental therapeutics.

Hypolipidemic effects of clofibrate and selected chroman analogs in fasted rats: I. Chow-fed animals

D. Witiak, J. Rice, H. A. Newman, 1981, Lipids.

Hypolipidemic effects of clofibrate and selected chroman analogs in fasted rats: II. High sucrose-fed animals

D. Witiak, J. Rice, H. A. Newman, 2006, Lipids.

Antilipidemic activity of 4-oxo-functionalized ethyl 6-chlorochroman-2-carboxylate analogs and a related tricyclic lactone in three rat models

D. Witiak, J. A. Minatelli, J. Baldwin, 2006, Lipids.

Evaluation of beta-adrenergic receptor subtypes in the human prostate cancer cell line-LNCaP.

D. Pasco, D. Feller, R. Salas, 2003, Biochemical pharmacology.

Comparison of hypocholesterolemic activity for cyclic analogs of clofibrate in normolipemic rats.

D. Witiak, D. Feller, A. Goldberg, 1977, Atherosclerosis.

1-Benzyl-1,2,3,4-tetrahydroisoquinoline-6,7-diols as novel affinity and photoaffinity probes for beta-adrenoceptor subtypes.

Duane D. Miller, D. Feller, R. Mehta, 2006, Bioorganic & medicinal chemistry.

Adrenergic Receptor Ligands

Duane D. Miller, B. Moore, D. Feller, 2006 .

Bioisosteric phentolamine analogs as potent α-adrenergic antagonists

Duane D. Miller, D. Feller, Supriya A. Bavadekar, 2005 .

Synthesis and biological studies of yohimbine derivatives on human α2C-adrenergic receptors

Duane D. Miller, B. Moore, D. Feller, 2005 .

Yohimbine Dimers Exhibiting Selectivity for the Human α2c-Adrenoceptor Subtype

Duane D. Miller, S. Liggett, B. Moore, 2002, Journal of Pharmacology and Experimental Therapeutics.

Biochemical Activities of Trimetoquinol Analogs at Human β1- and β3-Adrenergic Receptors

Duane D. Miller, R. Fertel, D. Feller, 2001, Pharmacology.

Yohimbine dimers exhibiting binding selectivities for human α2a-versus α2b-adrenergic receptors

Duane D. Miller, D. Feller, Weiping Zheng, 2000 .

Biochemical and functional characterization of 1-benzyl substituted trimetoquinol affinity analogs on rat and human β-adrenoceptors

Duane D. Miller, R. Fertel, D. Feller, 2000 .

Beta-adrenoceptor subtype activities of trimetoquinol derivatives: biochemical studies on human beta-adrenoceptors expressed in chinese hamster ovary cells.

R. Fertel, D. Miller, D. Feller, 1999, The Journal of pharmacology and experimental therapeutics.

b -Adrenoceptor Subtype Activities of Trimetoquinol Derivatives: Biochemical Studies on Human b -Adrenoceptors Expressed in Chinese Hamster Ovary Cells 1

Duane D. Miller, R. Fertel, D. Feller, 1999 .

Beta-adrenergic receptor and platelet inhibitory activities of a new series of trimetoquinol and related benzazepine analogs.

D. Miller, K. Romstedt, D. Feller, 1997, General pharmacology.

Cholesterol 7alpha-hydroxylase--evidence for a distinct hepatic microsomal enzyme system.

D. Witiak, D. Feller, W. Mellon, 1978, Biochemical pharmacology.

Diversity of the pharmacological actions of some tolazoline analogues in human platelets and rat aorta.

D. Miller, D. Feller, P. Patil, 1991, European journal of pharmacology.

Pharmacological properties of novel bicyclic isoquinoline analogs in isolated guinea pig atria, trachea and in human platelets: relationship to trimetoquinol.

V. Roche, A. Adejare, D. Miller, 1991, General pharmacology.

Pharmacologic antagonism of thromboxane A2 receptors by trimetoquinol analogs in vitro and in vivo.

M. Harrold, D. Miller, K. Romstedt, 1991, Chirality.

Characterization of the inhibition of U46619-mediated human platelet activation by the trimetoquinol isomers. Evidence for endoperoxide/thromboxane A2 receptor blockade.

L. Wallace, C. Ahn, D. Miller, 1988, Biochemical pharmacology.

Pharmacological study of atypical beta-adrenoceptors in rat esophageal smooth muscle.

D. Miller, D. Feller, M. Salazar-Bookaman, 1996, European journal of pharmacology.

Pharmacological evaluation of the beta-adrenoceptor agonist and thromboxane receptor blocking properties of 1-benzyl substituted trimetoquinol analogues.

M. Harrold, D. Miller, K. Romstedt, 1990, European journal of pharmacology.

Antagonism of prostaglandin-mediated responses in platelets and vascular smooth muscle by 13-azaprostanoic acid analogs. Evidence for selective blockade of thromboxane A2 responses.

D. Miller, K. Romstedt, D. Feller, 1985, Biochemical pharmacology.

Bronchoselective actions of a new series of trimetoquinol analogues.

D. Miller, D. Feller, J. Chang, 1981, European journal of pharmacology.

Comparative actions of the trimetoquinol, tetrahydropapaveroline and salsolinol isomers in beta-adrenoceptor systems.

D. Miller, D. Feller, R. Venkatraman, 1975, Biochemical pharmacology.

Effect of trimetoquinol analogs for antagonism of endoperoxide/thromboxane A2-mediated responses in human platelets and rat aorta.

D. Miller, D. Feller, S. A. Abdel-Aziz, 1985, The Journal of pharmacology and experimental therapeutics.

Differential effect of clofibrate on hepatic drug oxidation and cholesterol 7alpha-hydroxylation.

D. Witiak, D. Feller, A. Goldberg, 1976, Biochemical pharmacology.

Yohimbine Dimers Exhibiting Binding Selectivities for Human α2a- versus α2b-Adrenergic Receptors

Duane D. Miller, D. Feller, Weiping Zheng, 2000 .

An efficient cyclic AMP assay for the functional evaluation of beta-adrenergic receptor ligands.

D. Feller, S. Vansal, 1999, Journal of receptor and signal transduction research.

Lipolytic activity of structurally related agonists in rat epididymal fat tissue in vitro.

D. Feller, K. Finger, 1970, Biochemical pharmacology.

Influence of various agonists and antagonists on the release of free fatty acids from adipose tissue in vitro.

D. Feller, K. Finger, J. Page, 1966, Biochemical pharmacology.

Medetomidine analogs as selective agonists for the human alpha2-adrenoceptors.

Duane D. Miller, S. Liggett, Wei Li, 2004, Biochemical pharmacology.

Activation of peroxisome proliferator-activated receptor isoforms and inhibition of prostaglandin H2 synthases by ibuprofen, naproxen, and indomethacin11Abbreviations: AA, arachidonic acid; ACO, acyl-CoA oxidase; COX; cyclooxygenase; NSAIDs, nonsteroidal anti-inflammatory drugs; PGHS, prostaglandin

D. Noonan, K. Romstedt, D. Feller, 2001 .

Biotransformation of D(-)-ephedrine and L(+)-ephedrine in the rabbit, in vivo and in vitro.

L. Malspeis, D. Feller, 1977, Drug metabolism and disposition: the biological fate of chemicals.

Synthesis of halogenated trimetoquinol derivatives and evaluation of their beta-agonist and thromboxane A2 (TXA2) antagonist activities.

G Shams, V. Tantishaiyakul, V Tantishaiyakul, 1992, Journal of medicinal chemistry.

Medetomidine analogs as alpha 2-adrenergic ligands. 2. Design, synthesis, and biological activity of conformationally restricted naphthalene derivatives of medetomidine.

J. Dalton, D. Miller, D. Feller, 1996, Journal of medicinal chemistry.

Hypocholesterolemic and antiaggregatory properties of 2-hydroxytetronic acid redox analogues an their relationship to clofibric acid.

D. Witiak, D. Feller, S. Patel, 1982, Journal of medicinal chemistry.

Pseudolaric acid analogs as a new class of peroxisome proliferator-activated receptor agonists.

D. Noonan, M. Avery, D. Feller, 2002, Planta medica.

Diethyl (4baalpha,4calpha,9aalpha,9balpha)-3,6-dichlorocyclobuta[1,2-b:3,4-b']bisbenzofuran-9a,9b(4bH,4cH)-dicarboxylate: the cis,syn photodimer of ethyl 5-chlorobenzofuran-2-carboxylate, an analogue related to the antilipidemic drug clofibrate.

D. Witiak, J. Baldwin, H. A. Newman, 1978, Journal of medicinal chemistry.

HYPOCHOLESTEROLEMIC AND ANTIAGGREGATORY PROPERTIES OF 2-HYDROXYTETRONIC ACID REDOX ANALOGS AND THEIR RELATIONSHIP TO CLOFIBRIC ACID

D. Witiak, D. Feller, Suman T. Patel, 1982 .

Inhibitory action of -(4-chlorophenoxy)- -methylpropionic acid analogs on cholesterol biosynthesis and lipolysis in vitro.

D. Witiak, D. Feller, R. Hackney, 1971, Journal of medicinal chemistry.

Synthesis and pharmacological evaluation of a clofibrate-related tricyclic spirolactone, 5-chloro-4',5-dihydrospiro[benzofuran-2(3H),3'(2'H)-furan]-2'-one.

D. Witiak, J. Baldwin, H. A. Newman, 1978, Journal of medicinal chemistry.

Synthesis and biological evaluation of a tetrahydroisoquinoline derivative possessing selective beta2-adrenergic agonist activity.

P. Kador, D. Miller, D. Feller, 1977, Journal of medicinal chemistry.

6-Chlorochroman-2-carboxylic acids. Synthesis and biological evaluation as antagonists for cholesterol biosynthesis and lipolysis in vitro.

D. Witiak, D. Feller, E. S. Stratford, 1971, Journal of medicinal chemistry.

Synthesis and alpha-adrenergic activities of 2- and 4-substituted imidazoline and imidazole analogues.

D. Miller, K. Romstedt, D. Feller, 1992, Journal of medicinal chemistry.

Enzymatic reduction of niridazole by rat liver microsomes.

J. Gillette, D. Feller, M. Morita, 1971, Biochemical pharmacology.

Reduction of niridazole by rat liver santhine oxidase.

J. Gillette, D. Feller, M. Morita, 1971, Biochemical pharmacology.

Pharmacological effects of ephedrine alkaloids on human alpha(1)- and alpha(2)-adrenergic receptor subtypes.

I. Khan, G. Ma, D. Feller, 2007, The Journal of pharmacology and experimental therapeutics.

Pharmacological Effects of Ephedrine Alkaloids on Human α1- and α2-Adrenergic Receptor Subtypes

I. Khan, G. Ma, D. Feller, 2007, Journal of Pharmacology and Experimental Therapeutics.

Pharmacological Effects of Ephedrine Alkaloids on Human (cid:1) 1 - and (cid:1) 2 -Adrenergic Receptor Subtypes

I. Khan, D. Feller, R. Nagmani, 2007 .

Influence of substituted phenethylamines on lipolysis, in vitro. III. Stereoselectivity.

D. Miller, D. Feller, O. Lee, 1974, The Journal of pharmacology and experimental therapeutics.

Reduction of Heterocyclic Nitro Compounds in the Rat Liver

J. Gillette, D. Feller, M. Morita, 1971 .

Bioassay for the Identification of Natural Product-Based Activators of Peroxisome Proliferator-Activated Receptor-γ (PPARγ): The Marine Sponge Metabolite Psammaplin A Activates PPARγ and Induces Apoptosis in Human Breast Tumor Cells

D. Nagle, M. Avery, P. Desai, 2006 .

Inhibition of low density lipoprotein oxidation by thyronines and probucol.

D. Witiak, H. A. Newman, D. Feller, 1993, Biochemical pharmacology.

Synthesis of 1-substituted analogues of trimetoquinol possessing differential and selective beta-adrenergic properties.

D. Miller, D. Feller, R. Raman, 1977, Journal of medicinal chemistry.

Convergence of three steroid receptor pathways in the mediation of nongenotoxic hepatocarcinogenesis.

D. Noonan, D. Crick, C. Weinberger, 1996, Carcinogenesis.

Mechanisms of peroxisome proliferation by perfluorooctanoic acid and endogenous fatty acids.

D. Noonan, U Intrasuksri, D R Feller, 1998, General pharmacology.

Effects of the stereochemical orientation of phenethylamines and imidazolines on alpha-adrenergic receptor-mediated DNA synthesis in primary cultured rat hepatocytes.

D. Miller, D. Feller, T. Esbenshade, 1992, Chirality.

The microsomal N-demethylation of the stereoisomers of ephedrine.

J. F. Snell, D. Feller, R. Dann, 1971, European journal of pharmacology.

Resolution and adrenergic activities of the optical isomers of 4-[1-(1-naphthyl)ethyl]-1H-imidazole.

R. A. Lyon, D. Miller, K. Romstedt, 1992, Chirality.

Activation of L-type calcium channel by tolazoline derivatives: role of isothiocyanate moiety.

D. Miller, D. Feller, L. Lei, 1998, Journal of cardiovascular pharmacology.

Evidence for spironolactone as a possible inducer of liver microsomal enzymes in mice.

M. C. Gerald, D. Feller, 1970, Biochemical pharmacology.

Correlation of (+)‐amphetamine lethality and hepatic metabolism

D. Feller, P. Kramer, P. Basu, 1974, The Journal of pharmacy and pharmacology.

Interactions of spironolactone with hepatic microsomal drug-metabolizing enzyme systems.

M. C. Gerald, D. Feller, 1971, Biochemical pharmacology.

Stereostructure Activity Relationships of Catecholamines on Human Platelet Function

Duane D. Miller, C. Ahn, D. Feller, 1990, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Pharmacological activities of trimetoquinol and 1-benzyl halogen-substituted analogues on rat beta-adrenoceptor subtypes.

R. Fertel, D. Miller, D. Feller, 1996, European journal of pharmacology.

Interactions of the hexobarbital enantiomers with rat liver microsomes.

W. Lubawy, D. Feller, 1973, Pharmacology.

Effects of clofibrate and 6-substituted chroman analogs on human platelet function: mechanism of inhibitory action.

D. Witiak, H. A. Newman, D. Feller, 1981, Biochemical pharmacology.

Halogen-substituted trimetoquinol analogs as thromboxane A2 receptor antagonists in platelets and aorta.

V. Tantishaiyakul, A. Adejare, D. Miller, 1993, Biochemical pharmacology.

Potentiating effects of clofibrate on prostaglandin-dependent and -independent pathways of human platelet activation: evidence for involvement of cyclic AMP.

D. Witiak, R. Fertel, H. A. Newman, 1982, Biochemical pharmacology.

Antiplatelet actions of trimetoquinol isomers: evidence for inhibition of a prostaglandin-independent pathway of platelet aggregation.

D. Miller, D. Feller, H. Akbar, 1982, Biochemical pharmacology.

Investigation of the effects of phospholipase C on human platelets: evidence that aggregation induced by phospholipase C is independent of prostaglandin generation, released ADP and is modulated by cyclic AMP.

D. Miller, D. Feller, H. Akbar, 1982, Thrombosis research.

Differential effects of benzodioxane, chroman, and dihydrobenzofuran analogs of clofibrate on various parameters of hepatic drug metabolism.

D. Witiak, N. Lewis, D. Feller, 1974, Journal of medicinal chemistry.

Influence of Clofibrate (Ethyl-4-Chlorophenoxyisobutyrate) on Hepatic Drug Metabolism in Male Rats 1

D. Witiak, N. Lewis, D. Feller, 1974, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Calcium Channel‐Dependent and I1‐Imidazoline Receptor Binding Properties of 2‐(4′‐Isothiocyanatobenzyl) Imidazoline Analogs in Vascular and Brain Tissues fn1

P. Ernsberger, D. Miller, D. Feller, 1995, Annals of the New York Academy of Sciences.

Paradoxical effects of isothiocyanate analog of tolazoline on rat aorta and human platelets.

D. Miller, D. Feller, P. Patil, 1989, Blood & Vessel.

Molecular aspects of the receptor activation by imidazolines: an overview.

D. Miller, D. Feller, P. Patil, 1991, Journal of neural transmission. Supplementum.

Comparison of the effects of selected monocarboxylic, dicarboxylic and perfluorinated fatty acids on peroxisome proliferation in primary cultured rat hepatocytes.

U Intrasuksri, D R Feller, D. Feller, 1991, Biochemical pharmacology.

Activation of peroxisome proliferator-activated receptor isoforms and inhibition of prostaglandin H(2) synthases by ibuprofen, naproxen, and indomethacin.

D. Noonan, K. Romstedt, D. Feller, 2001, Biochemical pharmacology.

Alpha-adrenoceptor-mediated actions of optical isomers and desoxy analogs of catecholimidazoline and norepinephrine in human platelets: in vitro.

C. Ahn, D. Miller, D. Feller, 1986, Biochemical pharmacology.